首页 | 本学科首页   官方微博 | 高级检索  
检索        

白血病耐药细胞中多药耐药基因MDR1与核转录因子κB的关系
引用本文:杨冬艳,张宏字,孔晓霞,孙连坤,史纪文.白血病耐药细胞中多药耐药基因MDR1与核转录因子κB的关系[J].吉林大学学报(医学版),2009,35(4):650-655.
作者姓名:杨冬艳  张宏字  孔晓霞  孙连坤  史纪文
作者单位:吉林大学中日联谊医院超声科,吉林,长春,130033;吉林大学基础医学院病理生理学教研室,吉林,长春,130021
基金项目:吉林省科技厅科技发展计划 
摘    要:目的:研究核转录因子κB与多药耐药基因MDR1在白血病化疗耐药中的作用,阐明核转录因子κB(NF-κB)与白血病多药耐药的关系及相关分子机制。方法:白血病细胞K562和阿霉素(ADM)诱导的耐药细胞K562/ADM分别应用ADM(0、0.25、0.50、1.00和2.00 μg·L-1)或丝裂霉素(MIT)(0、2、4、8和16 mg·L-1) 作用48 h,通过MTT法检测细胞生存率,计算细胞耐药指数;RT-PCR方法检测MDR1和IκB mRNA表达;Western blotting方法检测P-gp和P65的蛋白表达。结果:ADM和MIT分别作用后,与空白对照组比较,白血病细胞K562细胞生存率下降(P<0.01),呈剂量依赖性;ADM和MIT对耐药细胞K562/ADM生存率作用不明显;在mRNA水平上,与K562细胞比较,K562/ADM细胞的MDR1 mRNA高表达(P<0.01)。与空白对照组比较,ADM 0.50和1.00  μg·L-1>或MIT 4和8 mg·L-1分别作用K562细胞和K562/ADM细胞,IκBα mRNA表达均下降(P<0.01),并呈剂量依赖性;在蛋白水平上,与K562细胞比较,K562/ADM细胞的P-gp蛋白高表达(P<0.01)。与空白对照组比较,ADM 0.50和1.00 μg·L-1或MIT 4和8 mg·L-1分别作用K562/ADM细胞,P-gp蛋白表达量升高(P<0.01),同时P65蛋白表达量升高,且呈药物剂量依赖性(P<0.01)。结论:MDR1基因及P-gp蛋白的高表达很可能是白血病细胞K562多药耐药性形成的关键机制,而NF-κB的激活可能参与了多药耐药的调控。

关 键 词:多药耐药基因  核转录因子kB  P65
收稿时间:2008-11-28

Relationship between multi-drug resistance gene MDR1 and NF-kappa B in human drug-resistance erythroleukemia cells
YANG Dong-yan,ZHANG Hong-yu,KONG Xiao-xia,SUN Lian-kun,SHI Ji-wen.Relationship between multi-drug resistance gene MDR1 and NF-kappa B in human drug-resistance erythroleukemia cells[J].Journal of Jilin University: Med Ed,2009,35(4):650-655.
Authors:YANG Dong-yan  ZHANG Hong-yu  KONG Xiao-xia  SUN Lian-kun  SHI Ji-wen
Institution:1.Department of Ultrasound,China-Japan Union Hospital,Jilin University,Changchun 130033,China;2.Department of Pathphysiology, School of Basic Medical Sciences,Jilin University,Changchun 130021,China
Abstract:Objective To observe the effect of nuclear factor kappa B(NF-κB) and multi-drug resistance gene MDR1 on leukemia chemotherapy resistance,to demonstrate the relationship between NF-κB and multidrug-resistance and the related mechanism.Methods Erythroleukemia cells K562 and adriamycin(ADM)-resistance cells K562/ADM were treated with ADM(0,0.25,0.50,1.00,2.00 μg·L-1) or mitomycin(MIT)(0,2,4,8,16 mg·L-1) for 48 h. The cell viability was detected by MTT assay,the cell resistant factor was calculated,MDR1 and IκB mRNA levels were detected by RT-PCR;Pgp and P65 protein levels were detected by Western blotting.Results Compared with control group,0.50 and 1.00 μg·L-1 ADM or 4 and 8 mg·L-1 MIT inhibited the cell viability significantly in erythroleukemia cells K562 in a dose-dependent manner(P<0.01);but had no significant effect on drug-resistance cells;on the mRNA level,compared with K562 cells,the expression level of MDR1 mRNA in K562/ADM cells was higher(P<0.01).Compared with control group,the expressions of IκBα mRNA decreased(P<0.01) in K562 cells or K562/ADM cells treated with 0.50 and 1.00 μg·L-1 ADM or 4 and 8 mg·L-1 MIT respectively in a dose-dependent manner.On the protein level,compared with K562 cells,the expression of P-gp protein increased(P<0.01);compared with control group,the expression of P-gp protein increased(P<0.01),the expression of P65 protein increased at the same time in a dose-dependent manner in K562/ADM cells treated with 0.50 and 1.00 μg·L-1 ADM or 4 and 8 mg·L-1 MIT(P<0.01).Conclusion The high expression of MDR1 gene and P-gp protein may be the essential mechanism of drug resistance in K562 cells,and the activation of NF-κB may be involved in the regulation of multi-drug resistance.
Keywords:P65
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《吉林大学学报(医学版)》浏览原始摘要信息
点击此处可从《吉林大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号